Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
Takashi Tsuchihashi,1 Keisuke Mori,1 Kuniko Horie-Inoue,2 Yasushi Okazaki,3 Takuya Awata,4,5 Satoshi Inoue,2 Shin Yoneya1 1Department of Ophthalmology, 2Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Johns Hopkins University School of Medicine,...
Guardado en:
Autores principales: | Tsuchihashi T, Mori K, Horie-Inoue K, Okazaki Y, Awata T, Inoue S, Yoneya S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/747ace7e16a44c089522ee4971eeaeb3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
por: Tsuchihashi T, et al.
Publicado: (2013) -
Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: José Mª Ruiz-Moreno, et al.
Publicado: (2008) -
Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
por: Kyoko Okada, et al.
Publicado: (2009) -
Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008) -
Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Pukhraj Rishi, et al.
Publicado: (2011)